Attention deficit hyperactivity disorder, combined type
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Acute myocardial infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
766
|
118
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Acute onset pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
53
|
6
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Asymmetric Septal Hypertrophy
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Disease or Syndrome
|
31
|
7
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Drug usage
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
170
|
21
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Sleeplessness
|
phenotype |
Nervous System Diseases; Mental Disorders
|
Sign or Symptom
|
174
|
30
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stress induced hyperglycaemia
|
disease |
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Central neuroblastoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
2419
|
231
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Major Depressive Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1236
|
1451
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Neurobehavioral Manifestations
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Sign or Symptom
|
77
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Metabolic Syndrome X
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1125
|
591
|
0.010 |
None |
< 0.001 |
1 |
|
2010 |
2010 |
Suicidal
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
93
|
29
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Acth-Independent Macronodular Adrenal Hyperplasia
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
46
|
8
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Venous Thromboembolism
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
378
|
408
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Colitis, Microscopic
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
30
|
3
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Adrenal Cushing's syndrome
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
120
|
9
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Learning Disabilities
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
103
|
5
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Alcoholic Steatohepatitis
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
30
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Ischemic stroke
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1159
|
704
|
0.010 |
None |
< 0.001 |
1 |
|
2013 |
2013 |
Unipolar Depression
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
641
|
225
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Stage IIA Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Fatty Liver Disease
|
disease |
|
Disease or Syndrome
|
741
|
81
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cardiovascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
1756
|
711
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Epilepsy, Temporal Lobe
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
354
|
33
|
0.010 |
None |
< 0.001 |
1 |
|
1998 |
1998 |